SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001193125-12-234886
Filing Date
2012-05-15
Accepted
2012-05-15 16:58:55
Documents
11
Period of Report
2012-03-31
Filing Date Changed
2012-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d329853d10q.htm 10-Q 301679
2 SECTION 302 CEO CERTIFICATION d329853dex311.htm EX-31.1 6409
3 SECTION 302 CFO CERTIFICATION d329853dex312.htm EX-31.2 6433
4 SECTION 906 CEO CERTIFICATION d329853dex321.htm EX-32.1 3870
5 SECTION 906 CFO CERTIFICATION d329853dex322.htm EX-32.2 3885
  Complete submission text file 0001193125-12-234886.txt   1426804

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ck0001401667-20120331.xml EX-101.INS 141867
7 XBRL TAXONOMY EXTENSION SCHEMA ck0001401667-20120331.xsd EX-101.SCH 11990
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001401667-20120331_cal.xml EX-101.CAL 25292
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001401667-20120331_def.xml EX-101.DEF 72574
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001401667-20120331_lab.xml EX-101.LAB 98227
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001401667-20120331_pre.xml EX-101.PRE 85933
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52811 | Film No.: 12845706
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1